Influence of a Inhaled Corticosteroid Therapy Versus Corticosteroid + LABA Therapy on the FeNO of Asthmatic Children

Allergic Asthma Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00515775
• Other study ID #: D5890L00015
• Status: Completed
• Phase: N/A
• First received: August 13, 2007
• Last updated: February 12, 2009
• Start date: September 2005
• Est. completion date: October 2008

Study information

• Verified date: October 2008
• Source: Technische Universität Dresden
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics Commission
• Study type: Observational

Clinical Trial Summary

The purpose of the study is to investigate, whether the FeNO concentration of asthmatic children is influenced differently by inhaled corticosteroid compared to inhaled corticosteroid + long acting beta agonist. The study hypothesis is that the FeNO concentration is more decreased in patients with a combination therapy compared to those with a corticosteroid mono therapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 27
• Est. completion date: October 2008
• Est. primary completion date: June 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 6 Years to 18 Years

Eligibility

Inclusion Criteria:

• allergic asthma since > 6 months equal or lower corticosteroid therapy before study entry FEV1>50%

Exclusion Criteria:

• severe asthma respiratory infection within the last 4 weeks smoking

Study Design

Observational Model: Case-Crossover, Time Perspective: Prospective

Related Conditions & MeSH terms

• Allergic Asthma

Locations

Country	Name	City	State
Germany	University Children´s Hospital, Technical University of Dresden	Dresden

Sponsors (1)

Lead Sponsor	Collaborator
Technische Universität Dresden

Country where clinical trial is conducted

Germany,